Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-05

FDA Approved: GLATOPA — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved Sandoz's supplemental application for GLATOPA, a generic glatiramer acetate product, for use in treating multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLATOPA (GLATIRAMER ACETATE)

Snippet

SUPPL AP for GLATOPA (GLATIRAMER ACETATE)